Medical Care
Global Natural Killer Cell Therapeutics Market Research Report 2025
- Jan 16, 26
- ID: 674836
- Pages: 73
- Figures: 75
- Views: 6
This report aims to provide a comprehensive presentation of the global market for Natural Killer Cell Therapeutics, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Natural Killer Cell Therapeutics.
The Natural Killer Cell Therapeutics market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Natural Killer Cell Therapeutics market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Natural Killer Cell Therapeutics companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Merck KGaA
Bristol-Myers Squibb Company
Glycostem
Sanofi
Cytovia Therapeutics
ImmunityBio, Inc.
Biohaven Pharmaceuticals
Fate Therapeutics
EMERcell
Phio Pharmaceuticals
Segment by Type
NK Cell Therapies
NK Cell Directed Antibodies
Segment by Application
Research & Academic Institutes
Hospitals
Specialty Clinics
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Natural Killer Cell Therapeutics company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
The Natural Killer Cell Therapeutics market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Natural Killer Cell Therapeutics market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Natural Killer Cell Therapeutics companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Merck KGaA
Bristol-Myers Squibb Company
Glycostem
Sanofi
Cytovia Therapeutics
ImmunityBio, Inc.
Biohaven Pharmaceuticals
Fate Therapeutics
EMERcell
Phio Pharmaceuticals
Segment by Type
NK Cell Therapies
NK Cell Directed Antibodies
Segment by Application
Research & Academic Institutes
Hospitals
Specialty Clinics
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Natural Killer Cell Therapeutics company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Natural Killer Cell Therapeutics Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 NK Cell Therapies
1.2.3 NK Cell Directed Antibodies
1.3 Market by Application
1.3.1 Global Natural Killer Cell Therapeutics Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Research & Academic Institutes
1.3.3 Hospitals
1.3.4 Specialty Clinics
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Natural Killer Cell Therapeutics Market Perspective (2020-2031)
2.2 Global Natural Killer Cell Therapeutics Growth Trends by Region
2.2.1 Global Natural Killer Cell Therapeutics Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Natural Killer Cell Therapeutics Historic Market Size by Region (2020-2025)
2.2.3 Natural Killer Cell Therapeutics Forecasted Market Size by Region (2026-2031)
2.3 Natural Killer Cell Therapeutics Market Dynamics
2.3.1 Natural Killer Cell Therapeutics Industry Trends
2.3.2 Natural Killer Cell Therapeutics Market Drivers
2.3.3 Natural Killer Cell Therapeutics Market Challenges
2.3.4 Natural Killer Cell Therapeutics Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Natural Killer Cell Therapeutics Players by Revenue
3.1.1 Global Top Natural Killer Cell Therapeutics Players by Revenue (2020-2025)
3.1.2 Global Natural Killer Cell Therapeutics Revenue Market Share by Players (2020-2025)
3.2 Global Natural Killer Cell Therapeutics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Natural Killer Cell Therapeutics Revenue
3.4 Global Natural Killer Cell Therapeutics Market Concentration Ratio
3.4.1 Global Natural Killer Cell Therapeutics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Natural Killer Cell Therapeutics Revenue in 2024
3.5 Global Key Players of Natural Killer Cell Therapeutics Head office and Area Served
3.6 Global Key Players of Natural Killer Cell Therapeutics, Product and Application
3.7 Global Key Players of Natural Killer Cell Therapeutics, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Natural Killer Cell Therapeutics Breakdown Data by Type
4.1 Global Natural Killer Cell Therapeutics Historic Market Size by Type (2020-2025)
4.2 Global Natural Killer Cell Therapeutics Forecasted Market Size by Type (2026-2031)
5 Natural Killer Cell Therapeutics Breakdown Data by Application
5.1 Global Natural Killer Cell Therapeutics Historic Market Size by Application (2020-2025)
5.2 Global Natural Killer Cell Therapeutics Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Natural Killer Cell Therapeutics Market Size (2020-2031)
6.2 North America Natural Killer Cell Therapeutics Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Natural Killer Cell Therapeutics Market Size by Country (2020-2025)
6.4 North America Natural Killer Cell Therapeutics Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Natural Killer Cell Therapeutics Market Size (2020-2031)
7.2 Europe Natural Killer Cell Therapeutics Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Natural Killer Cell Therapeutics Market Size by Country (2020-2025)
7.4 Europe Natural Killer Cell Therapeutics Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Natural Killer Cell Therapeutics Market Size (2020-2031)
8.2 Asia-Pacific Natural Killer Cell Therapeutics Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Natural Killer Cell Therapeutics Market Size by Region (2020-2025)
8.4 Asia-Pacific Natural Killer Cell Therapeutics Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Natural Killer Cell Therapeutics Market Size (2020-2031)
9.2 Latin America Natural Killer Cell Therapeutics Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Natural Killer Cell Therapeutics Market Size by Country (2020-2025)
9.4 Latin America Natural Killer Cell Therapeutics Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Natural Killer Cell Therapeutics Market Size (2020-2031)
10.2 Middle East & Africa Natural Killer Cell Therapeutics Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Natural Killer Cell Therapeutics Market Size by Country (2020-2025)
10.4 Middle East & Africa Natural Killer Cell Therapeutics Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Merck KGaA
11.1.1 Merck KGaA Company Details
11.1.2 Merck KGaA Business Overview
11.1.3 Merck KGaA Natural Killer Cell Therapeutics Introduction
11.1.4 Merck KGaA Revenue in Natural Killer Cell Therapeutics Business (2020-2025)
11.1.5 Merck KGaA Recent Development
11.2 Bristol-Myers Squibb Company
11.2.1 Bristol-Myers Squibb Company Company Details
11.2.2 Bristol-Myers Squibb Company Business Overview
11.2.3 Bristol-Myers Squibb Company Natural Killer Cell Therapeutics Introduction
11.2.4 Bristol-Myers Squibb Company Revenue in Natural Killer Cell Therapeutics Business (2020-2025)
11.2.5 Bristol-Myers Squibb Company Recent Development
11.3 Glycostem
11.3.1 Glycostem Company Details
11.3.2 Glycostem Business Overview
11.3.3 Glycostem Natural Killer Cell Therapeutics Introduction
11.3.4 Glycostem Revenue in Natural Killer Cell Therapeutics Business (2020-2025)
11.3.5 Glycostem Recent Development
11.4 Sanofi
11.4.1 Sanofi Company Details
11.4.2 Sanofi Business Overview
11.4.3 Sanofi Natural Killer Cell Therapeutics Introduction
11.4.4 Sanofi Revenue in Natural Killer Cell Therapeutics Business (2020-2025)
11.4.5 Sanofi Recent Development
11.5 Cytovia Therapeutics
11.5.1 Cytovia Therapeutics Company Details
11.5.2 Cytovia Therapeutics Business Overview
11.5.3 Cytovia Therapeutics Natural Killer Cell Therapeutics Introduction
11.5.4 Cytovia Therapeutics Revenue in Natural Killer Cell Therapeutics Business (2020-2025)
11.5.5 Cytovia Therapeutics Recent Development
11.6 ImmunityBio, Inc.
11.6.1 ImmunityBio, Inc. Company Details
11.6.2 ImmunityBio, Inc. Business Overview
11.6.3 ImmunityBio, Inc. Natural Killer Cell Therapeutics Introduction
11.6.4 ImmunityBio, Inc. Revenue in Natural Killer Cell Therapeutics Business (2020-2025)
11.6.5 ImmunityBio, Inc. Recent Development
11.7 Biohaven Pharmaceuticals
11.7.1 Biohaven Pharmaceuticals Company Details
11.7.2 Biohaven Pharmaceuticals Business Overview
11.7.3 Biohaven Pharmaceuticals Natural Killer Cell Therapeutics Introduction
11.7.4 Biohaven Pharmaceuticals Revenue in Natural Killer Cell Therapeutics Business (2020-2025)
11.7.5 Biohaven Pharmaceuticals Recent Development
11.8 Fate Therapeutics
11.8.1 Fate Therapeutics Company Details
11.8.2 Fate Therapeutics Business Overview
11.8.3 Fate Therapeutics Natural Killer Cell Therapeutics Introduction
11.8.4 Fate Therapeutics Revenue in Natural Killer Cell Therapeutics Business (2020-2025)
11.8.5 Fate Therapeutics Recent Development
11.9 EMERcell
11.9.1 EMERcell Company Details
11.9.2 EMERcell Business Overview
11.9.3 EMERcell Natural Killer Cell Therapeutics Introduction
11.9.4 EMERcell Revenue in Natural Killer Cell Therapeutics Business (2020-2025)
11.9.5 EMERcell Recent Development
11.10 Phio Pharmaceuticals
11.10.1 Phio Pharmaceuticals Company Details
11.10.2 Phio Pharmaceuticals Business Overview
11.10.3 Phio Pharmaceuticals Natural Killer Cell Therapeutics Introduction
11.10.4 Phio Pharmaceuticals Revenue in Natural Killer Cell Therapeutics Business (2020-2025)
11.10.5 Phio Pharmaceuticals Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Natural Killer Cell Therapeutics Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 NK Cell Therapies
1.2.3 NK Cell Directed Antibodies
1.3 Market by Application
1.3.1 Global Natural Killer Cell Therapeutics Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Research & Academic Institutes
1.3.3 Hospitals
1.3.4 Specialty Clinics
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Natural Killer Cell Therapeutics Market Perspective (2020-2031)
2.2 Global Natural Killer Cell Therapeutics Growth Trends by Region
2.2.1 Global Natural Killer Cell Therapeutics Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Natural Killer Cell Therapeutics Historic Market Size by Region (2020-2025)
2.2.3 Natural Killer Cell Therapeutics Forecasted Market Size by Region (2026-2031)
2.3 Natural Killer Cell Therapeutics Market Dynamics
2.3.1 Natural Killer Cell Therapeutics Industry Trends
2.3.2 Natural Killer Cell Therapeutics Market Drivers
2.3.3 Natural Killer Cell Therapeutics Market Challenges
2.3.4 Natural Killer Cell Therapeutics Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Natural Killer Cell Therapeutics Players by Revenue
3.1.1 Global Top Natural Killer Cell Therapeutics Players by Revenue (2020-2025)
3.1.2 Global Natural Killer Cell Therapeutics Revenue Market Share by Players (2020-2025)
3.2 Global Natural Killer Cell Therapeutics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Natural Killer Cell Therapeutics Revenue
3.4 Global Natural Killer Cell Therapeutics Market Concentration Ratio
3.4.1 Global Natural Killer Cell Therapeutics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Natural Killer Cell Therapeutics Revenue in 2024
3.5 Global Key Players of Natural Killer Cell Therapeutics Head office and Area Served
3.6 Global Key Players of Natural Killer Cell Therapeutics, Product and Application
3.7 Global Key Players of Natural Killer Cell Therapeutics, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Natural Killer Cell Therapeutics Breakdown Data by Type
4.1 Global Natural Killer Cell Therapeutics Historic Market Size by Type (2020-2025)
4.2 Global Natural Killer Cell Therapeutics Forecasted Market Size by Type (2026-2031)
5 Natural Killer Cell Therapeutics Breakdown Data by Application
5.1 Global Natural Killer Cell Therapeutics Historic Market Size by Application (2020-2025)
5.2 Global Natural Killer Cell Therapeutics Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Natural Killer Cell Therapeutics Market Size (2020-2031)
6.2 North America Natural Killer Cell Therapeutics Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Natural Killer Cell Therapeutics Market Size by Country (2020-2025)
6.4 North America Natural Killer Cell Therapeutics Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Natural Killer Cell Therapeutics Market Size (2020-2031)
7.2 Europe Natural Killer Cell Therapeutics Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Natural Killer Cell Therapeutics Market Size by Country (2020-2025)
7.4 Europe Natural Killer Cell Therapeutics Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Natural Killer Cell Therapeutics Market Size (2020-2031)
8.2 Asia-Pacific Natural Killer Cell Therapeutics Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Natural Killer Cell Therapeutics Market Size by Region (2020-2025)
8.4 Asia-Pacific Natural Killer Cell Therapeutics Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Natural Killer Cell Therapeutics Market Size (2020-2031)
9.2 Latin America Natural Killer Cell Therapeutics Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Natural Killer Cell Therapeutics Market Size by Country (2020-2025)
9.4 Latin America Natural Killer Cell Therapeutics Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Natural Killer Cell Therapeutics Market Size (2020-2031)
10.2 Middle East & Africa Natural Killer Cell Therapeutics Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Natural Killer Cell Therapeutics Market Size by Country (2020-2025)
10.4 Middle East & Africa Natural Killer Cell Therapeutics Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Merck KGaA
11.1.1 Merck KGaA Company Details
11.1.2 Merck KGaA Business Overview
11.1.3 Merck KGaA Natural Killer Cell Therapeutics Introduction
11.1.4 Merck KGaA Revenue in Natural Killer Cell Therapeutics Business (2020-2025)
11.1.5 Merck KGaA Recent Development
11.2 Bristol-Myers Squibb Company
11.2.1 Bristol-Myers Squibb Company Company Details
11.2.2 Bristol-Myers Squibb Company Business Overview
11.2.3 Bristol-Myers Squibb Company Natural Killer Cell Therapeutics Introduction
11.2.4 Bristol-Myers Squibb Company Revenue in Natural Killer Cell Therapeutics Business (2020-2025)
11.2.5 Bristol-Myers Squibb Company Recent Development
11.3 Glycostem
11.3.1 Glycostem Company Details
11.3.2 Glycostem Business Overview
11.3.3 Glycostem Natural Killer Cell Therapeutics Introduction
11.3.4 Glycostem Revenue in Natural Killer Cell Therapeutics Business (2020-2025)
11.3.5 Glycostem Recent Development
11.4 Sanofi
11.4.1 Sanofi Company Details
11.4.2 Sanofi Business Overview
11.4.3 Sanofi Natural Killer Cell Therapeutics Introduction
11.4.4 Sanofi Revenue in Natural Killer Cell Therapeutics Business (2020-2025)
11.4.5 Sanofi Recent Development
11.5 Cytovia Therapeutics
11.5.1 Cytovia Therapeutics Company Details
11.5.2 Cytovia Therapeutics Business Overview
11.5.3 Cytovia Therapeutics Natural Killer Cell Therapeutics Introduction
11.5.4 Cytovia Therapeutics Revenue in Natural Killer Cell Therapeutics Business (2020-2025)
11.5.5 Cytovia Therapeutics Recent Development
11.6 ImmunityBio, Inc.
11.6.1 ImmunityBio, Inc. Company Details
11.6.2 ImmunityBio, Inc. Business Overview
11.6.3 ImmunityBio, Inc. Natural Killer Cell Therapeutics Introduction
11.6.4 ImmunityBio, Inc. Revenue in Natural Killer Cell Therapeutics Business (2020-2025)
11.6.5 ImmunityBio, Inc. Recent Development
11.7 Biohaven Pharmaceuticals
11.7.1 Biohaven Pharmaceuticals Company Details
11.7.2 Biohaven Pharmaceuticals Business Overview
11.7.3 Biohaven Pharmaceuticals Natural Killer Cell Therapeutics Introduction
11.7.4 Biohaven Pharmaceuticals Revenue in Natural Killer Cell Therapeutics Business (2020-2025)
11.7.5 Biohaven Pharmaceuticals Recent Development
11.8 Fate Therapeutics
11.8.1 Fate Therapeutics Company Details
11.8.2 Fate Therapeutics Business Overview
11.8.3 Fate Therapeutics Natural Killer Cell Therapeutics Introduction
11.8.4 Fate Therapeutics Revenue in Natural Killer Cell Therapeutics Business (2020-2025)
11.8.5 Fate Therapeutics Recent Development
11.9 EMERcell
11.9.1 EMERcell Company Details
11.9.2 EMERcell Business Overview
11.9.3 EMERcell Natural Killer Cell Therapeutics Introduction
11.9.4 EMERcell Revenue in Natural Killer Cell Therapeutics Business (2020-2025)
11.9.5 EMERcell Recent Development
11.10 Phio Pharmaceuticals
11.10.1 Phio Pharmaceuticals Company Details
11.10.2 Phio Pharmaceuticals Business Overview
11.10.3 Phio Pharmaceuticals Natural Killer Cell Therapeutics Introduction
11.10.4 Phio Pharmaceuticals Revenue in Natural Killer Cell Therapeutics Business (2020-2025)
11.10.5 Phio Pharmaceuticals Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
Table 1. Global Natural Killer Cell Therapeutics Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of NK Cell Therapies
Table 3. Key Players of NK Cell Directed Antibodies
Table 4. Global Natural Killer Cell Therapeutics Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 5. Global Natural Killer Cell Therapeutics Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 6. Global Natural Killer Cell Therapeutics Market Size by Region (2020-2025) & (US$ Million)
Table 7. Global Natural Killer Cell Therapeutics Market Share by Region (2020-2025)
Table 8. Global Natural Killer Cell Therapeutics Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 9. Global Natural Killer Cell Therapeutics Market Share by Region (2026-2031)
Table 10. Natural Killer Cell Therapeutics Market Trends
Table 11. Natural Killer Cell Therapeutics Market Drivers
Table 12. Natural Killer Cell Therapeutics Market Challenges
Table 13. Natural Killer Cell Therapeutics Market Restraints
Table 14. Global Natural Killer Cell Therapeutics Revenue by Players (2020-2025) & (US$ Million)
Table 15. Global Natural Killer Cell Therapeutics Market Share by Players (2020-2025)
Table 16. Global Top Natural Killer Cell Therapeutics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Natural Killer Cell Therapeutics as of 2024)
Table 17. Ranking of Global Top Natural Killer Cell Therapeutics Companies by Revenue (US$ Million) in 2024
Table 18. Global 5 Largest Players Market Share by Natural Killer Cell Therapeutics Revenue (CR5 and HHI) & (2020-2025)
Table 19. Global Key Players of Natural Killer Cell Therapeutics, Headquarters and Area Served
Table 20. Global Key Players of Natural Killer Cell Therapeutics, Product and Application
Table 21. Global Key Players of Natural Killer Cell Therapeutics, Date of Enter into This Industry
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Natural Killer Cell Therapeutics Market Size by Type (2020-2025) & (US$ Million)
Table 24. Global Natural Killer Cell Therapeutics Revenue Market Share by Type (2020-2025)
Table 25. Global Natural Killer Cell Therapeutics Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 26. Global Natural Killer Cell Therapeutics Revenue Market Share by Type (2026-2031)
Table 27. Global Natural Killer Cell Therapeutics Market Size by Application (2020-2025) & (US$ Million)
Table 28. Global Natural Killer Cell Therapeutics Revenue Market Share by Application (2020-2025)
Table 29. Global Natural Killer Cell Therapeutics Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 30. Global Natural Killer Cell Therapeutics Revenue Market Share by Application (2026-2031)
Table 31. North America Natural Killer Cell Therapeutics Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 32. North America Natural Killer Cell Therapeutics Market Size by Country (2020-2025) & (US$ Million)
Table 33. North America Natural Killer Cell Therapeutics Market Size by Country (2026-2031) & (US$ Million)
Table 34. Europe Natural Killer Cell Therapeutics Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 35. Europe Natural Killer Cell Therapeutics Market Size by Country (2020-2025) & (US$ Million)
Table 36. Europe Natural Killer Cell Therapeutics Market Size by Country (2026-2031) & (US$ Million)
Table 37. Asia-Pacific Natural Killer Cell Therapeutics Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 38. Asia-Pacific Natural Killer Cell Therapeutics Market Size by Region (2020-2025) & (US$ Million)
Table 39. Asia-Pacific Natural Killer Cell Therapeutics Market Size by Region (2026-2031) & (US$ Million)
Table 40. Latin America Natural Killer Cell Therapeutics Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 41. Latin America Natural Killer Cell Therapeutics Market Size by Country (2020-2025) & (US$ Million)
Table 42. Latin America Natural Killer Cell Therapeutics Market Size by Country (2026-2031) & (US$ Million)
Table 43. Middle East & Africa Natural Killer Cell Therapeutics Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 44. Middle East & Africa Natural Killer Cell Therapeutics Market Size by Country (2020-2025) & (US$ Million)
Table 45. Middle East & Africa Natural Killer Cell Therapeutics Market Size by Country (2026-2031) & (US$ Million)
Table 46. Merck KGaA Company Details
Table 47. Merck KGaA Business Overview
Table 48. Merck KGaA Natural Killer Cell Therapeutics Product
Table 49. Merck KGaA Revenue in Natural Killer Cell Therapeutics Business (2020-2025) & (US$ Million)
Table 50. Merck KGaA Recent Development
Table 51. Bristol-Myers Squibb Company Company Details
Table 52. Bristol-Myers Squibb Company Business Overview
Table 53. Bristol-Myers Squibb Company Natural Killer Cell Therapeutics Product
Table 54. Bristol-Myers Squibb Company Revenue in Natural Killer Cell Therapeutics Business (2020-2025) & (US$ Million)
Table 55. Bristol-Myers Squibb Company Recent Development
Table 56. Glycostem Company Details
Table 57. Glycostem Business Overview
Table 58. Glycostem Natural Killer Cell Therapeutics Product
Table 59. Glycostem Revenue in Natural Killer Cell Therapeutics Business (2020-2025) & (US$ Million)
Table 60. Glycostem Recent Development
Table 61. Sanofi Company Details
Table 62. Sanofi Business Overview
Table 63. Sanofi Natural Killer Cell Therapeutics Product
Table 64. Sanofi Revenue in Natural Killer Cell Therapeutics Business (2020-2025) & (US$ Million)
Table 65. Sanofi Recent Development
Table 66. Cytovia Therapeutics Company Details
Table 67. Cytovia Therapeutics Business Overview
Table 68. Cytovia Therapeutics Natural Killer Cell Therapeutics Product
Table 69. Cytovia Therapeutics Revenue in Natural Killer Cell Therapeutics Business (2020-2025) & (US$ Million)
Table 70. Cytovia Therapeutics Recent Development
Table 71. ImmunityBio, Inc. Company Details
Table 72. ImmunityBio, Inc. Business Overview
Table 73. ImmunityBio, Inc. Natural Killer Cell Therapeutics Product
Table 74. ImmunityBio, Inc. Revenue in Natural Killer Cell Therapeutics Business (2020-2025) & (US$ Million)
Table 75. ImmunityBio, Inc. Recent Development
Table 76. Biohaven Pharmaceuticals Company Details
Table 77. Biohaven Pharmaceuticals Business Overview
Table 78. Biohaven Pharmaceuticals Natural Killer Cell Therapeutics Product
Table 79. Biohaven Pharmaceuticals Revenue in Natural Killer Cell Therapeutics Business (2020-2025) & (US$ Million)
Table 80. Biohaven Pharmaceuticals Recent Development
Table 81. Fate Therapeutics Company Details
Table 82. Fate Therapeutics Business Overview
Table 83. Fate Therapeutics Natural Killer Cell Therapeutics Product
Table 84. Fate Therapeutics Revenue in Natural Killer Cell Therapeutics Business (2020-2025) & (US$ Million)
Table 85. Fate Therapeutics Recent Development
Table 86. EMERcell Company Details
Table 87. EMERcell Business Overview
Table 88. EMERcell Natural Killer Cell Therapeutics Product
Table 89. EMERcell Revenue in Natural Killer Cell Therapeutics Business (2020-2025) & (US$ Million)
Table 90. EMERcell Recent Development
Table 91. Phio Pharmaceuticals Company Details
Table 92. Phio Pharmaceuticals Business Overview
Table 93. Phio Pharmaceuticals Natural Killer Cell Therapeutics Product
Table 94. Phio Pharmaceuticals Revenue in Natural Killer Cell Therapeutics Business (2020-2025) & (US$ Million)
Table 95. Phio Pharmaceuticals Recent Development
Table 96. Research Programs/Design for This Report
Table 97. Key Data Information from Secondary Sources
Table 98. Key Data Information from Primary Sources
Table 99. Authors List of This Report
List of Figures
Figure 1. Natural Killer Cell Therapeutics Picture
Figure 2. Global Natural Killer Cell Therapeutics Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Natural Killer Cell Therapeutics Market Share by Type: 2024 VS 2031
Figure 4. NK Cell Therapies Features
Figure 5. NK Cell Directed Antibodies Features
Figure 6. Global Natural Killer Cell Therapeutics Market Size by Application (2020-2031) & (US$ Million)
Figure 7. Global Natural Killer Cell Therapeutics Market Share by Application: 2024 VS 2031
Figure 8. Research & Academic Institutes Case Studies
Figure 9. Hospitals Case Studies
Figure 10. Specialty Clinics Case Studies
Figure 11. Natural Killer Cell Therapeutics Report Years Considered
Figure 12. Global Natural Killer Cell Therapeutics Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 13. Global Natural Killer Cell Therapeutics Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 14. Global Natural Killer Cell Therapeutics Market Share by Region: 2024 VS 2031
Figure 15. Global Natural Killer Cell Therapeutics Market Share by Players in 2024
Figure 16. Global Top Natural Killer Cell Therapeutics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Natural Killer Cell Therapeutics as of 2024)
Figure 17. The Top 10 and 5 Players Market Share by Natural Killer Cell Therapeutics Revenue in 2024
Figure 18. North America Natural Killer Cell Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 19. North America Natural Killer Cell Therapeutics Market Share by Country (2020-2031)
Figure 20. United States Natural Killer Cell Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 21. Canada Natural Killer Cell Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 22. Europe Natural Killer Cell Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 23. Europe Natural Killer Cell Therapeutics Market Share by Country (2020-2031)
Figure 24. Germany Natural Killer Cell Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 25. France Natural Killer Cell Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 26. U.K. Natural Killer Cell Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 27. Italy Natural Killer Cell Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 28. Russia Natural Killer Cell Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. Nordic Countries Natural Killer Cell Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. Asia-Pacific Natural Killer Cell Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 31. Asia-Pacific Natural Killer Cell Therapeutics Market Share by Region (2020-2031)
Figure 32. China Natural Killer Cell Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 33. Japan Natural Killer Cell Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 34. South Korea Natural Killer Cell Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 35. Southeast Asia Natural Killer Cell Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. India Natural Killer Cell Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. Australia Natural Killer Cell Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. Latin America Natural Killer Cell Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. Latin America Natural Killer Cell Therapeutics Market Share by Country (2020-2031)
Figure 40. Mexico Natural Killer Cell Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 41. Brazil Natural Killer Cell Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 42. Middle East & Africa Natural Killer Cell Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 43. Middle East & Africa Natural Killer Cell Therapeutics Market Share by Country (2020-2031)
Figure 44. Turkey Natural Killer Cell Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 45. Saudi Arabia Natural Killer Cell Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 46. UAE Natural Killer Cell Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 47. Merck KGaA Revenue Growth Rate in Natural Killer Cell Therapeutics Business (2020-2025)
Figure 48. Bristol-Myers Squibb Company Revenue Growth Rate in Natural Killer Cell Therapeutics Business (2020-2025)
Figure 49. Glycostem Revenue Growth Rate in Natural Killer Cell Therapeutics Business (2020-2025)
Figure 50. Sanofi Revenue Growth Rate in Natural Killer Cell Therapeutics Business (2020-2025)
Figure 51. Cytovia Therapeutics Revenue Growth Rate in Natural Killer Cell Therapeutics Business (2020-2025)
Figure 52. ImmunityBio, Inc. Revenue Growth Rate in Natural Killer Cell Therapeutics Business (2020-2025)
Figure 53. Biohaven Pharmaceuticals Revenue Growth Rate in Natural Killer Cell Therapeutics Business (2020-2025)
Figure 54. Fate Therapeutics Revenue Growth Rate in Natural Killer Cell Therapeutics Business (2020-2025)
Figure 55. EMERcell Revenue Growth Rate in Natural Killer Cell Therapeutics Business (2020-2025)
Figure 56. Phio Pharmaceuticals Revenue Growth Rate in Natural Killer Cell Therapeutics Business (2020-2025)
Figure 57. Bottom-up and Top-down Approaches for This Report
Figure 58. Data Triangulation
Figure 59. Key Executives Interviewed
Table 1. Global Natural Killer Cell Therapeutics Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of NK Cell Therapies
Table 3. Key Players of NK Cell Directed Antibodies
Table 4. Global Natural Killer Cell Therapeutics Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 5. Global Natural Killer Cell Therapeutics Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 6. Global Natural Killer Cell Therapeutics Market Size by Region (2020-2025) & (US$ Million)
Table 7. Global Natural Killer Cell Therapeutics Market Share by Region (2020-2025)
Table 8. Global Natural Killer Cell Therapeutics Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 9. Global Natural Killer Cell Therapeutics Market Share by Region (2026-2031)
Table 10. Natural Killer Cell Therapeutics Market Trends
Table 11. Natural Killer Cell Therapeutics Market Drivers
Table 12. Natural Killer Cell Therapeutics Market Challenges
Table 13. Natural Killer Cell Therapeutics Market Restraints
Table 14. Global Natural Killer Cell Therapeutics Revenue by Players (2020-2025) & (US$ Million)
Table 15. Global Natural Killer Cell Therapeutics Market Share by Players (2020-2025)
Table 16. Global Top Natural Killer Cell Therapeutics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Natural Killer Cell Therapeutics as of 2024)
Table 17. Ranking of Global Top Natural Killer Cell Therapeutics Companies by Revenue (US$ Million) in 2024
Table 18. Global 5 Largest Players Market Share by Natural Killer Cell Therapeutics Revenue (CR5 and HHI) & (2020-2025)
Table 19. Global Key Players of Natural Killer Cell Therapeutics, Headquarters and Area Served
Table 20. Global Key Players of Natural Killer Cell Therapeutics, Product and Application
Table 21. Global Key Players of Natural Killer Cell Therapeutics, Date of Enter into This Industry
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Natural Killer Cell Therapeutics Market Size by Type (2020-2025) & (US$ Million)
Table 24. Global Natural Killer Cell Therapeutics Revenue Market Share by Type (2020-2025)
Table 25. Global Natural Killer Cell Therapeutics Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 26. Global Natural Killer Cell Therapeutics Revenue Market Share by Type (2026-2031)
Table 27. Global Natural Killer Cell Therapeutics Market Size by Application (2020-2025) & (US$ Million)
Table 28. Global Natural Killer Cell Therapeutics Revenue Market Share by Application (2020-2025)
Table 29. Global Natural Killer Cell Therapeutics Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 30. Global Natural Killer Cell Therapeutics Revenue Market Share by Application (2026-2031)
Table 31. North America Natural Killer Cell Therapeutics Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 32. North America Natural Killer Cell Therapeutics Market Size by Country (2020-2025) & (US$ Million)
Table 33. North America Natural Killer Cell Therapeutics Market Size by Country (2026-2031) & (US$ Million)
Table 34. Europe Natural Killer Cell Therapeutics Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 35. Europe Natural Killer Cell Therapeutics Market Size by Country (2020-2025) & (US$ Million)
Table 36. Europe Natural Killer Cell Therapeutics Market Size by Country (2026-2031) & (US$ Million)
Table 37. Asia-Pacific Natural Killer Cell Therapeutics Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 38. Asia-Pacific Natural Killer Cell Therapeutics Market Size by Region (2020-2025) & (US$ Million)
Table 39. Asia-Pacific Natural Killer Cell Therapeutics Market Size by Region (2026-2031) & (US$ Million)
Table 40. Latin America Natural Killer Cell Therapeutics Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 41. Latin America Natural Killer Cell Therapeutics Market Size by Country (2020-2025) & (US$ Million)
Table 42. Latin America Natural Killer Cell Therapeutics Market Size by Country (2026-2031) & (US$ Million)
Table 43. Middle East & Africa Natural Killer Cell Therapeutics Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 44. Middle East & Africa Natural Killer Cell Therapeutics Market Size by Country (2020-2025) & (US$ Million)
Table 45. Middle East & Africa Natural Killer Cell Therapeutics Market Size by Country (2026-2031) & (US$ Million)
Table 46. Merck KGaA Company Details
Table 47. Merck KGaA Business Overview
Table 48. Merck KGaA Natural Killer Cell Therapeutics Product
Table 49. Merck KGaA Revenue in Natural Killer Cell Therapeutics Business (2020-2025) & (US$ Million)
Table 50. Merck KGaA Recent Development
Table 51. Bristol-Myers Squibb Company Company Details
Table 52. Bristol-Myers Squibb Company Business Overview
Table 53. Bristol-Myers Squibb Company Natural Killer Cell Therapeutics Product
Table 54. Bristol-Myers Squibb Company Revenue in Natural Killer Cell Therapeutics Business (2020-2025) & (US$ Million)
Table 55. Bristol-Myers Squibb Company Recent Development
Table 56. Glycostem Company Details
Table 57. Glycostem Business Overview
Table 58. Glycostem Natural Killer Cell Therapeutics Product
Table 59. Glycostem Revenue in Natural Killer Cell Therapeutics Business (2020-2025) & (US$ Million)
Table 60. Glycostem Recent Development
Table 61. Sanofi Company Details
Table 62. Sanofi Business Overview
Table 63. Sanofi Natural Killer Cell Therapeutics Product
Table 64. Sanofi Revenue in Natural Killer Cell Therapeutics Business (2020-2025) & (US$ Million)
Table 65. Sanofi Recent Development
Table 66. Cytovia Therapeutics Company Details
Table 67. Cytovia Therapeutics Business Overview
Table 68. Cytovia Therapeutics Natural Killer Cell Therapeutics Product
Table 69. Cytovia Therapeutics Revenue in Natural Killer Cell Therapeutics Business (2020-2025) & (US$ Million)
Table 70. Cytovia Therapeutics Recent Development
Table 71. ImmunityBio, Inc. Company Details
Table 72. ImmunityBio, Inc. Business Overview
Table 73. ImmunityBio, Inc. Natural Killer Cell Therapeutics Product
Table 74. ImmunityBio, Inc. Revenue in Natural Killer Cell Therapeutics Business (2020-2025) & (US$ Million)
Table 75. ImmunityBio, Inc. Recent Development
Table 76. Biohaven Pharmaceuticals Company Details
Table 77. Biohaven Pharmaceuticals Business Overview
Table 78. Biohaven Pharmaceuticals Natural Killer Cell Therapeutics Product
Table 79. Biohaven Pharmaceuticals Revenue in Natural Killer Cell Therapeutics Business (2020-2025) & (US$ Million)
Table 80. Biohaven Pharmaceuticals Recent Development
Table 81. Fate Therapeutics Company Details
Table 82. Fate Therapeutics Business Overview
Table 83. Fate Therapeutics Natural Killer Cell Therapeutics Product
Table 84. Fate Therapeutics Revenue in Natural Killer Cell Therapeutics Business (2020-2025) & (US$ Million)
Table 85. Fate Therapeutics Recent Development
Table 86. EMERcell Company Details
Table 87. EMERcell Business Overview
Table 88. EMERcell Natural Killer Cell Therapeutics Product
Table 89. EMERcell Revenue in Natural Killer Cell Therapeutics Business (2020-2025) & (US$ Million)
Table 90. EMERcell Recent Development
Table 91. Phio Pharmaceuticals Company Details
Table 92. Phio Pharmaceuticals Business Overview
Table 93. Phio Pharmaceuticals Natural Killer Cell Therapeutics Product
Table 94. Phio Pharmaceuticals Revenue in Natural Killer Cell Therapeutics Business (2020-2025) & (US$ Million)
Table 95. Phio Pharmaceuticals Recent Development
Table 96. Research Programs/Design for This Report
Table 97. Key Data Information from Secondary Sources
Table 98. Key Data Information from Primary Sources
Table 99. Authors List of This Report
List of Figures
Figure 1. Natural Killer Cell Therapeutics Picture
Figure 2. Global Natural Killer Cell Therapeutics Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Natural Killer Cell Therapeutics Market Share by Type: 2024 VS 2031
Figure 4. NK Cell Therapies Features
Figure 5. NK Cell Directed Antibodies Features
Figure 6. Global Natural Killer Cell Therapeutics Market Size by Application (2020-2031) & (US$ Million)
Figure 7. Global Natural Killer Cell Therapeutics Market Share by Application: 2024 VS 2031
Figure 8. Research & Academic Institutes Case Studies
Figure 9. Hospitals Case Studies
Figure 10. Specialty Clinics Case Studies
Figure 11. Natural Killer Cell Therapeutics Report Years Considered
Figure 12. Global Natural Killer Cell Therapeutics Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 13. Global Natural Killer Cell Therapeutics Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 14. Global Natural Killer Cell Therapeutics Market Share by Region: 2024 VS 2031
Figure 15. Global Natural Killer Cell Therapeutics Market Share by Players in 2024
Figure 16. Global Top Natural Killer Cell Therapeutics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Natural Killer Cell Therapeutics as of 2024)
Figure 17. The Top 10 and 5 Players Market Share by Natural Killer Cell Therapeutics Revenue in 2024
Figure 18. North America Natural Killer Cell Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 19. North America Natural Killer Cell Therapeutics Market Share by Country (2020-2031)
Figure 20. United States Natural Killer Cell Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 21. Canada Natural Killer Cell Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 22. Europe Natural Killer Cell Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 23. Europe Natural Killer Cell Therapeutics Market Share by Country (2020-2031)
Figure 24. Germany Natural Killer Cell Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 25. France Natural Killer Cell Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 26. U.K. Natural Killer Cell Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 27. Italy Natural Killer Cell Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 28. Russia Natural Killer Cell Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. Nordic Countries Natural Killer Cell Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. Asia-Pacific Natural Killer Cell Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 31. Asia-Pacific Natural Killer Cell Therapeutics Market Share by Region (2020-2031)
Figure 32. China Natural Killer Cell Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 33. Japan Natural Killer Cell Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 34. South Korea Natural Killer Cell Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 35. Southeast Asia Natural Killer Cell Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. India Natural Killer Cell Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. Australia Natural Killer Cell Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. Latin America Natural Killer Cell Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. Latin America Natural Killer Cell Therapeutics Market Share by Country (2020-2031)
Figure 40. Mexico Natural Killer Cell Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 41. Brazil Natural Killer Cell Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 42. Middle East & Africa Natural Killer Cell Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 43. Middle East & Africa Natural Killer Cell Therapeutics Market Share by Country (2020-2031)
Figure 44. Turkey Natural Killer Cell Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 45. Saudi Arabia Natural Killer Cell Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 46. UAE Natural Killer Cell Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 47. Merck KGaA Revenue Growth Rate in Natural Killer Cell Therapeutics Business (2020-2025)
Figure 48. Bristol-Myers Squibb Company Revenue Growth Rate in Natural Killer Cell Therapeutics Business (2020-2025)
Figure 49. Glycostem Revenue Growth Rate in Natural Killer Cell Therapeutics Business (2020-2025)
Figure 50. Sanofi Revenue Growth Rate in Natural Killer Cell Therapeutics Business (2020-2025)
Figure 51. Cytovia Therapeutics Revenue Growth Rate in Natural Killer Cell Therapeutics Business (2020-2025)
Figure 52. ImmunityBio, Inc. Revenue Growth Rate in Natural Killer Cell Therapeutics Business (2020-2025)
Figure 53. Biohaven Pharmaceuticals Revenue Growth Rate in Natural Killer Cell Therapeutics Business (2020-2025)
Figure 54. Fate Therapeutics Revenue Growth Rate in Natural Killer Cell Therapeutics Business (2020-2025)
Figure 55. EMERcell Revenue Growth Rate in Natural Killer Cell Therapeutics Business (2020-2025)
Figure 56. Phio Pharmaceuticals Revenue Growth Rate in Natural Killer Cell Therapeutics Business (2020-2025)
Figure 57. Bottom-up and Top-down Approaches for This Report
Figure 58. Data Triangulation
Figure 59. Key Executives Interviewed
Our team would be happy to assist you with your queries.
About us
Accurate data, The latest market trends, And deeper research directions.
Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals
Latest reports
Global Smart Grid Digital Substation Market Research Report 2026
Mar 17, 26
Global Photovoltaic Molded Case Circuit Breaker Market Research Report 2026
Mar 17, 26
Global Roll-Roll Automobile Business Market Research Report 2026
Mar 17, 26
Useful links
Our Contacts
Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China
(+86) 159 1069 5232